Sponsor or institution
Clinical trials and research at Versiti Blood Health, INC.
As of November 12, 2026, Find a Trial lists 28 NIH-funded research projects at this institution, with $21.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 28NIH research projects
NIH-funded research (28)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Tissue-resident memory CD8+ T cell growth: how these frontline cells multiply in tissues
Aims to understand how tissue-resident memory CD8+ T cells grow and renew themselves inside body tissues to better fight infections and cancer.
-
Endothelial Rap1 and retinal inflammation in diabetes
A study in people with diabetic eye disease is exploring how a signaling protein in blood vessel cells of the retina might control inflammation and leakage to protect vision.
-
CD39-bearing tiny vesicles may guard lungs in SCD patients
A study in people with sickle cell disease explores whether extracellular vesicles carrying CD39 protect the lungs from blood clots during acute illness.
-
Non-conventional signaling by α5 integrin in blood and endothelial cells
This grant studies how the α5 integrin in blood and blood vessel cells communicates signals that affect cell behavior and may relate to inflammation and blood clotting in infectious diseases.
-
Long-acting RNA therapy to control fibrinolysis and reduce bleeding
A new RNA treatment delivered in lipids aims to slow down fibrinolysis and lessen bleeding for people with bleeding disorders or severe hemorrhage.
-
Understanding how TFPI-alpha blocks blood clotting in adults
This NIH grant studies how a specific protein fragment called TFPI-alpha helps prevent blood clots in adults, aiming to understand its interactions with factors that start and propagate clotting.
-
How sugar tags help the body remove old platelets
This project looks at how sugar markers on platelets tell the liver to clear old platelets and how that signaling affects platelet and red blood cell production.
-
Immunobiology of vaccine-related clotting after adenovirus vaccines
This research asks how antibodies linked to a rare vaccine-related clotting condition (VITT) interact with specific blood proteins to cause clots after certain COVID-19 vaccines.
-
Understanding and diagnosing Heparin-Induced Thrombocytopenia (HIT)
A project to understand the immune factors behind HIT and develop faster, more accurate tests to help people who need heparin therapy.
-
Fetal and neonatal platelet allergy: understanding why some babies bleed
A study to understand why maternal antibodies cause serious bleeding in babies with FNAIT, using an animal model and human-relevant clues to improve future care for affected families.
-
Protein production and sequencing to study antibody-related low platelet conditions
A multi-project effort at Versiti Blood Health to understand how certain antibodies and platelet proteins cause dangerous low-platelet conditions, using protein production, structural biology, and advanced 16S sequencing technologies.
-
Administrative Core for a Blood Research Program
A central team supports a multi-project program focused on blood diseases, helping researchers manage resources, meetings, and compliance.
-
Molecular mechanisms behind immune-related low platelets and clots in transfusion medicine
This grant supports a team of researchers to understand how immune factors cause low platelets and abnormal clots, with a focus on transfusion medicine and pediatric to adult patients.
-
How fetal hemoglobin is distributed in red blood cells in sickle cell disease
Aims to understand why fetal hemoglobin is unevenly spread among red blood cells in people with sickle cell disease and how this affects illness.
-
Understanding the immune signals behind heparin-induced HIT
This grant looks at how the body’s immune system creates antibodies that cause a dangerous reaction to heparin, aiming to improve detection and prevention for patients who need this medication.
-
How a mother's immune reaction can cause newborn low platelets (FNAIT)
This project aims to find markers that show which pregnancies are at high risk for severe fetal or newborn low platelets (FNAIT) so affected mothers and babies can get more targeted care.
-
Targeted treatment for inv(16) acute myeloid leukemia (CBFβ‑SMMHC)
Using a targeted drug combination to kill leukemia cells in adults with inv(16) acute myeloid leukemia.
-
How cell attachment proteins change shape and what that means for blood clotting
This project looks at how proteins on blood cells change shape to help design safer treatments for blood clots.
-
Rap1 protein helps reduce inflammation in the retina
This project looks at how the Rap1 protein in blood-vessel cells may keep inflammation down in people with diabetic retinopathy.
-
Understanding Blood Clotting After Certain Vaccines
This research looks into why some people develop unusual blood clots and low platelet counts after certain COVID-19 vaccines.
-
Understanding Heparin-Induced Thrombocytopenia
This project aims to better understand and diagnose a serious blood condition called heparin-induced thrombocytopenia, which can occur after receiving heparin medication.
-
Understanding a Bleeding Disorder in Newborns Caused by Mother's Antibodies
This research explores why some babies develop a severe bleeding disorder called FNAIT, where a mother's antibodies reduce her baby's platelets.
-
Understanding Blood Clotting Disorders Caused by Antibodies
This project helps scientists better understand certain blood clotting disorders where the body's own antibodies cause problems.
-
Understanding Immune Blood Disorders Affecting Platelets
This program explores how the immune system causes low platelet counts and blood clots in people of all ages, from newborns to adults.
-
How the α5 integrin protein affects blood and blood-vessel cells' reaction to the coronavirus spike
Researchers are looking at whether a protein on blood and blood‑vessel cells called α5 integrin helps the coronavirus spike protein trigger inflammation and clotting signals.
-
A New Long-Lasting RNA Treatment for Bleeding Disorders
This work explores how blood clot breakdown contributes to bleeding and aims to create a new, long-acting RNA medicine to help people with bleeding disorders.
-
Blood vesicles carrying CD39 and lung clots in sickle cell disease
This research looks at whether tiny particles in the blood that carry CD39 can help prevent dangerous lung blood clots in people with sickle cell disease.
-
Understanding how a protein called TFPI-alpha helps control blood clotting
This project aims to understand how a natural protein in our blood, TFPI-alpha, helps prevent unwanted blood clots and contributes to healthy blood flow.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.